| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 05/08/2007 | US7214699 Indazole derivatives as CRF antagonists |
| 05/08/2007 | US7214698 Beta-agonists, processes for preparing them and their use as pharmaceutical compositions |
| 05/08/2007 | US7214697 2-Oxo-benzimidazolyl substituted ethanolamine derivatives and their use as β3 agonists |
| 05/08/2007 | US7214693 Contraceptices; hormone sensitivity diseases; antidepressants; sexual disorders ; osteoporosis; alopecia |
| 05/08/2007 | US7214691 For therapy of metabolic and eating disorders |
| 05/08/2007 | US7214679 treatment of inflammation, proliferative diseases, and certain cardiovascular disorders as well as Alzheimer's disease; |
| 05/08/2007 | US7214676 Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 05/08/2007 | US7214674 Heterocyclymethylpiperidines and -piperazines possessing affinity at 5ht-1 type receptors |
| 05/08/2007 | US7214506 Method for treating onychomycosis |
| 05/08/2007 | CA2331870C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 05/03/2007 | WO2007050522A1 Derivatives for modulation of ion channels |
| 05/03/2007 | WO2007050375A2 Piperazine derivatives useful as ccr5 antagonists |
| 05/03/2007 | WO2007049914A1 S-omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same |
| 05/03/2007 | WO2007049820A1 Heterocyclic amide compound and use thereof |
| 05/03/2007 | WO2007048841A2 Novel indole-containing beta agonists, method for producing them and their use as drugs |
| 05/03/2007 | WO2007048788A1 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
| 05/03/2007 | WO2007048779A1 Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists |
| 05/03/2007 | WO2007048771A1 Arylurea derivatives as modulators of chemokine receptor activity |
| 05/03/2007 | WO2007048767A1 Squaric acid derivatives as inhibitors of histone deacetylase |
| 05/03/2007 | WO2007048733A1 Use of 5-aminopyrazoles for controlling plant-pathogenic fungi, novel 5-aminopyrazoles, method for their production and agents containing said compounds |
| 05/03/2007 | WO2007032936A3 Azafused cyclin dependent kinase inhibitors |
| 05/03/2007 | WO2007030939A3 Methods of modulating neurotrophin-mediated activity |
| 05/03/2007 | WO2007027528A3 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-.receptor tyrosine kinases |
| 05/03/2007 | WO2007025776A3 Cysteine protease inhibitors |
| 05/03/2007 | WO2007021711A3 Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 05/03/2007 | WO2007011626A3 Histone deacetylase inhibitors |
| 05/03/2007 | WO2007009120A3 Heterotetracyclic compounds as tpo mimetics |
| 05/03/2007 | WO2006123257A3 Phenyl-3-{(3-(1h-pyrrol-2-yl)-[1, 2 , 4]0xadiaz0l-5-yl]piperidin-1-yl}-methanone derivatives and related compounds as positive allosteric modulators of metabotropic glutamate receptors |
| 05/03/2007 | WO2006111560A3 2,3 substituted pyrazine sulfonamides as inhibitors of crth2 |
| 05/03/2007 | WO2006106432A3 4-arylpiperidine derivatives and use thereof for preparing a medicament for the treatment of cns disorders |
| 05/03/2007 | US20070100141 Substituted piperazines and piperidines as modulators of the neuropeptide y2 receptor |
| 05/03/2007 | US20070099962 5,6-Dihydropyrin-2-one compounds useful as inhibitors of thrombin |
| 05/03/2007 | US20070099961 Method for producing bactericidal pyridine compound and bactericidal pyridine compound |
| 05/03/2007 | US20070099960 Liver X receptors (LXR) modulators such as 1-[[4-(1,1-dimethylethyl)phenyl]sulfonyl]-4-methoxy-N-(2-phenyl ethyl)-2,3-dihydro-1H-)indole-2-carboxamide, used for the treatment of atherosclerosis, dyslipidemia, obesity, diabetes, hypercholesterolemia, neurodegenerative diseases and inflammatory diseases |
| 05/03/2007 | US20070099957 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 05/03/2007 | US20070099944 ROCK-1 kinase and/or Aurora kinase inhibitors; indazolo-tetrahydropyrimidine-carboxamide derivatives; 4-(4-fluorophenyl)-N-1H-indazol-5-yl-6-methyl-2-oxo-1,2,3,4-tetrahydro-5-pyrimidinecarboxamide; antiinflammatory, antidiabetic, antiproliferative agents |
| 05/03/2007 | US20070099943 Quinazoline derivatives |
| 05/03/2007 | US20070099935 Azole-based kinase inhibitors |
| 05/03/2007 | US20070099934 N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b |
| 05/03/2007 | US20070099927 Aminoalkyl-pyrazinones and-pyridones as thrombin inhibitors |
| 05/03/2007 | US20070099924 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 05/03/2007 | US20070099922 For use as anticoagulant agents for therapy of thromboembolic disorders; 6-chloro-naphthalene-2-sulfonic acid [1-(1-cyclopentyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide; )-2-methyl-benzothiazole-6-sulfonic acid [1-(1-isopropyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide |
| 05/03/2007 | US20070099921 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/03/2007 | US20070099916 nuclear hormone receptor inhibitors; to treat increased lipid levels, increased cholesterol levels, low HDL-cholesterol, high LDL-cholesterol, atherosclerotic diseases, diabetes, macular degeneration, Alzheimer's disease; 2-(1-benzyl-3-chloro-2-methyl-1H-indol-5-yl)-1,1,1,3,3,3-hexafluoro-propan-2-ol |
| 05/03/2007 | US20070099909 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor |
| 05/03/2007 | US20070099897 Therapeutic compounds |
| 05/03/2007 | US20070099895 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof |
| 05/03/2007 | US20070099874 Methods and compositions of novel triazine compounds |
| 05/03/2007 | US20070099873 Quinolines useful as modulators of ion channels |
| 05/03/2007 | DE102005012873B4 Aminocarbonyl substituierte 8-N-Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Aminocarbonyl substituted 8-N-benzimidazoles, process for their preparation and their use as medicaments |
| 05/03/2007 | CA2627497A1 Heterocyclic amide compound and use thereof |
| 05/03/2007 | CA2627486A1 Novel indole-containing beta agonists, method for producing them and their use as drugs |
| 05/03/2007 | CA2626565A1 Piperazine derivatives useful as ccr5 antagonists |
| 05/03/2007 | CA2626324A1 Arylurea derivatives as modulators of chemokine receptor activity |
| 05/03/2007 | CA2626190A1 Derivatives for modulation of ion channels |
| 05/03/2007 | CA2623879A1 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
| 05/03/2007 | CA2623360A1 Squaric acid derivatives as inhibitors of histone deacetylase |
| 05/03/2007 | CA2623160A1 Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists |
| 05/02/2007 | EP1780211A2 Vanilloid receptor ligands and their use in treatments |
| 05/02/2007 | EP1780207A2 Crystalline esomeprazole strontium hydrate, method for preparing the same and pharmaceutical composition containing the same |
| 05/02/2007 | EP1780206A1 Use of 5-amino pyrazoles for fighting plant pathogenic fungi, new 5-amino pyrazoles, method for their production and agents containing them |
| 05/02/2007 | EP1780203A2 Enantioselective alkylation of tricyclic compounds |
| 05/02/2007 | EP1780201A2 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |
| 05/02/2007 | EP1780196A2 Pyridine derivatives for use as vanilloid receptor ligands |
| 05/02/2007 | EP1778684A1 4-PIPERAZINYL-PYRIMIDINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D<sb>3</sb> RECEPTOR |
| 05/02/2007 | EP1778681A1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 05/02/2007 | EP1778676A1 Hydantoin derivatives for the treatment of inflammatory disorders |
| 05/02/2007 | EP1778673A1 Novel hydantoin derivatives for the treatment of obstructive airway diseases |
| 05/02/2007 | EP1778672A1 Crystalline form of a biphenyl compound |
| 05/02/2007 | EP1778671A1 Piperazine derivatives with ccr3 inhibiting activity |
| 05/02/2007 | EP1778670A2 Medicinal use of receptor ligands |
| 05/02/2007 | EP1778669A2 Kinase inhibitors |
| 05/02/2007 | EP1778668A2 Method for the production of dihydropteridinones |
| 05/02/2007 | EP1778658A2 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| 05/02/2007 | EP1778648A2 Compounds useful for inhibiting chk1 |
| 05/02/2007 | EP1778646A1 Mercaptoimidazoles as ccr2 receptor antagonists |
| 05/02/2007 | EP1778643A1 Tetrahydrobenzazepines as antagonists and/or reverse agonists of the histamine h3 receptor |
| 05/02/2007 | EP1778642A1 5-ht7 receptor antagonosts |
| 05/02/2007 | EP1778641A1 5-ht7 receptor antagonists |
| 05/02/2007 | EP1778637A2 Fkbp binding composition and pharmaceutical use thereof |
| 05/02/2007 | EP1778634A1 Isoindolone compounds and their use as metabotropic glutamate receptor potentiators |
| 05/02/2007 | EP1778633A1 Indoles useful in the treatment of inflammation |
| 05/02/2007 | EP1778632A1 Indoles useful in the treatment of inflammation |
| 05/02/2007 | EP1778233A1 Intracellular receptor modulator compounds and methods |
| 05/02/2007 | EP1778231A1 Chemical compounds |
| 05/02/2007 | EP1778229A2 Amido compounds and their use as pharmaceuticals |
| 05/02/2007 | EP1608645B1 Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses |
| 05/02/2007 | EP1575942B1 compounds having selective inhibiting efect at gsk3 |
| 05/02/2007 | EP1537111B1 Hetereoaryl nitrile derivatives |
| 05/02/2007 | EP1458707B1 New Indol-2-one derivatives |
| 05/02/2007 | EP1458685B1 Substituted phenyl derivatives |
| 05/02/2007 | EP1441723B1 Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension |
| 05/02/2007 | EP1395606B1 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
| 05/02/2007 | EP1358184B1 N-(3,3-Dimethylindolin-6-yl){2-[(4-pyridylmethyl)amino}(3-pyridyl)}carboxamide and pharmaceutical compositions thereof. |
| 05/02/2007 | EP1322608B1 Delta1-pyrrolines used as pesticides |
| 05/02/2007 | EP1268478B1 Phenyl-substituted imidazopyridines |
| 05/02/2007 | CN1956980A Mercaptoimidazoles as CCR2 receptor antagonists |
| 05/02/2007 | CN1956976A Mercaptoimidazoles as CCR2 receptor antagonists |
| 05/02/2007 | CN1956975A Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity |
| 05/02/2007 | CN1956974A 2-substituted pyrimidines and their use as pesticides |